Second Sight to Discuss Third Quarter 2019 Financial Results on November 14, 2019 Conference Call
Thursday, November 14, 2019
Time
4:30 p.m. EST
Toll free (U.S.)
(800) 771-6759
International
(212) 231-2937
Second Sight Medical Products, Inc. (EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind individuals, will release its financial results for the third quarter of 2019 on Thursday, November 14, 2019, after the close of the U.S. financial markets.
Will McGuire, President and Chief Executive Officer, and John T. Blake, Chief Financial Officer, will host a conference call to discuss the results as follows:
Webcast (live and replay)
www.secondsight.com under the ‘Investors’ section.
A replay of the conference call will be available for two weeks after the call's completion by dialing (800) 633-8284 (U.S.) or (402) 977-9140 (International). The conference ID for the replay is 21933121. The archived webcast will be available for 30 days via the aforementioned URL.
About Second Sight
Second Sight Medical Products, Inc. (EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company’s U.S. headquarters are in Los Angeles, California, and European headquarters are in Lausanne, Switzerland. More information is available at www.secondsight.com.
